ZA200804218B - Process for the manufacture of epoxybutanol intermediates - Google Patents

Process for the manufacture of epoxybutanol intermediates

Info

Publication number
ZA200804218B
ZA200804218B ZA200804218A ZA200804218A ZA200804218B ZA 200804218 B ZA200804218 B ZA 200804218B ZA 200804218 A ZA200804218 A ZA 200804218A ZA 200804218 A ZA200804218 A ZA 200804218A ZA 200804218 B ZA200804218 B ZA 200804218B
Authority
ZA
South Africa
Prior art keywords
manufacture
formula
epoxybutanol
intermediates
ethyl
Prior art date
Application number
ZA200804218A
Other languages
English (en)
Inventor
Muller Marc
Xu Lin
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of ZA200804218B publication Critical patent/ZA200804218B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
ZA200804218A 2005-12-01 2008-05-15 Process for the manufacture of epoxybutanol intermediates ZA200804218B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01

Publications (1)

Publication Number Publication Date
ZA200804218B true ZA200804218B (en) 2009-01-28

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804218A ZA200804218B (en) 2005-12-01 2008-05-15 Process for the manufacture of epoxybutanol intermediates

Country Status (19)

Country Link
US (2) US7816537B2 (sl)
EP (2) EP2133345A1 (sl)
JP (1) JP5329969B2 (sl)
KR (1) KR101191682B1 (sl)
CN (1) CN101321522B (sl)
AT (1) ATE444747T1 (sl)
AU (2) AU2006319657B2 (sl)
BR (1) BRPI0619120B1 (sl)
CA (2) CA2711852C (sl)
CY (1) CY1110588T1 (sl)
DE (1) DE602006009698D1 (sl)
DK (1) DK1954264T3 (sl)
ES (1) ES2333258T3 (sl)
HR (1) HRP20090675T1 (sl)
PL (1) PL1954264T3 (sl)
PT (1) PT1954264E (sl)
SI (1) SI1954264T1 (sl)
WO (1) WO2007062542A2 (sl)
ZA (1) ZA200804218B (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10023600B2 (en) 2009-09-21 2018-07-17 Gilead Sciences, Inc. Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
SG186830A1 (en) 2010-07-22 2013-02-28 Gilead Sciences Inc Methods and compounds for treating paramyxoviridae virus infections
WO2014023623A1 (en) 2012-08-07 2014-02-13 Basilea Pharmaceutica Ag Process for the manufacture of isavuconazole or ravuconazole
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI698444B (zh) 2014-10-29 2020-07-11 美商基利科學股份有限公司 製備核糖苷的方法
BR112018005048B8 (pt) 2015-09-16 2021-03-23 Gilead Sciences Inc uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
AU2018235754B2 (en) 2017-03-14 2021-04-08 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
ES2938859T3 (es) 2017-05-01 2023-04-17 Gilead Sciences Inc Una forma cristalina de (S)-2-etilbutilo 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato
CN111093627B (zh) 2017-07-11 2024-03-08 吉利德科学公司 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
ES2915582T3 (es) 2017-08-10 2022-06-23 Sumitomo Chemical Co Método para producir un compuesto de alcohol epoxi
CN118766947A (zh) 2020-01-27 2024-10-15 吉利德科学公司 用于治疗SARS CoV-2感染的方法
WO2021183750A2 (en) 2020-03-12 2021-09-16 Gilead Sciences, Inc. Methods of preparing 1'-cyano nucleosides
KR20220164784A (ko) 2020-04-06 2022-12-13 길리애드 사이언시즈, 인코포레이티드 1'-시아노 치환된 카르바뉴클레오시드 유사체의 흡입 제형
CN115666570A (zh) 2020-05-29 2023-01-31 吉利德科学公司 瑞德西韦治疗方法
EP4172160A2 (en) 2020-06-24 2023-05-03 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
CA3190702A1 (en) 2020-08-27 2022-03-03 Elaine Bunyan Compounds and methods for treatment of viral infections
TW202400185A (zh) 2022-03-02 2024-01-01 美商基利科學股份有限公司 用於治療病毒感染的化合物及方法
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
AU2931399A (en) 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6133485A (en) 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
ATE444747T1 (de) 2009-10-15
CA2629092A1 (en) 2007-06-07
PL1954264T3 (pl) 2010-02-26
AU2006319657B2 (en) 2010-08-12
EP2133345A1 (en) 2009-12-16
BRPI0619120B1 (pt) 2023-10-10
CA2711852C (en) 2011-10-04
ES2333258T3 (es) 2010-02-18
AU2006319657A1 (en) 2007-06-07
HRP20090675T1 (hr) 2010-01-31
DE602006009698D1 (de) 2009-11-19
JP5329969B2 (ja) 2013-10-30
AU2010203301A1 (en) 2010-08-12
US20090299073A1 (en) 2009-12-03
CA2629092C (en) 2012-01-03
CN101321522B (zh) 2012-05-30
AU2010203301B2 (en) 2012-06-21
PT1954264E (pt) 2009-12-23
EP1954264A2 (en) 2008-08-13
US20110021794A1 (en) 2011-01-27
CN101321522A (zh) 2008-12-10
BRPI0619120A2 (pt) 2011-09-13
KR20080075014A (ko) 2008-08-13
JP2009517413A (ja) 2009-04-30
US7816537B2 (en) 2010-10-19
KR101191682B1 (ko) 2012-10-16
EP1954264B1 (en) 2009-10-07
SI1954264T1 (sl) 2010-01-29
WO2007062542A3 (en) 2007-11-01
US8076494B2 (en) 2011-12-13
CA2711852A1 (en) 2007-06-07
WO2007062542A2 (en) 2007-06-07
CY1110588T1 (el) 2015-04-29
DK1954264T3 (da) 2010-01-11

Similar Documents

Publication Publication Date Title
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
HK1139381A1 (en) Bicyclic -amino acid derivative
NO20062644L (no) DPP-IV inhibitorer
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
SE0202838D0 (sv) Chemical compounds
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
HK1159614A1 (en) Caspase inhibitors and uses thereof
HK1164114A1 (en) Antidepressant containing heterocyclic compound having specific structure
PT2161260E (pt) Processo de semi síntese para a preparação do 10-desacetiln- desbenzoil-paclitaxel
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
HUP0401600A2 (hu) Eljárás 14-hidroximorfin-származékok előállítására
UA96149C2 (en) Method for producing 4-oxoquinoline compound
HK1088604A1 (en) Process for the production of 1-acetoxy-3- (substituted phenyl) propenes
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
NO20053997D0 (no) Oligosaccharidderivat
SE0402734D0 (sv) Antimiicrobial compounds
EP1557407A4 (en) NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
EP1489076A4 (en) CYCLIC HEMIACETAL DERIVATIVE AND USE THEREOF